David P. Langlois (DL 2319) SUTHERLAND ... - FDA Law Blog
David P. Langlois (DL 2319) SUTHERLAND ... - FDA Law Blog
David P. Langlois (DL 2319) SUTHERLAND ... - FDA Law Blog
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Case 1:09-cv-04665-<strong>DL</strong>C Document 49-2 Filed 03/30/2010 Page 19 of 45151. Teva denies the allegations in Paragraph 151.152. Teva denies the allegations in Paragraph 152.153. Teva denies the allegations in Paragraph 153.Teva denies that Takeda is entitled to any relief requested in paragraphs (a) through (g) ofits “prayer for relief.”AFFIRMATIVE DEFENSESFIRST AFFIRMATIVE DEFENSETeva has not infringed, is not infringing, will not infringe, and will not contribute to orinduce infringement of, literally or under the Doctrine of Equivalents, any valid and enforceableclaim of the ‘584 patent.SECOND AFFIRMATIVE DEFENSETeva has not infringed, is not infringing, will not infringe, and will not contribute to orinduce infringement of, literally or under the Doctrine of Equivalents, any valid and enforceableclaim of the ‘404 patent.THIRD AFFIRMATIVE DEFENSETeva has not infringed, is not infringing, will not infringe, and will not contribute to orinduce infringement of, literally or under the Doctrine of Equivalents, any valid and enforceableclaim of the ‘043 patent.FOURTH AFFIRMATIVE DEFENSETeva has not infringed, is not infringing, will not infringe, and will not contribute to orinduce infringement of, literally or under the Doctrine of Equivalents, any valid and enforceableclaim of the ‘090 patent.9067383.118